| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 36.600 | 38.492 | 41.314 | 59.927 | 59.753 | 103.563 | 61.907 |
| Total Income - EUR | - | - | - | 39.830 | 57.924 | 51.776 | 65.429 | 68.787 | 121.002 | 222.104 |
| Total Expenses - EUR | - | - | - | 17.925 | 36.985 | 29.682 | 30.016 | 56.586 | 85.193 | 76.157 |
| Gross Profit/Loss - EUR | - | - | - | 21.905 | 20.939 | 22.094 | 35.413 | 12.201 | 35.809 | 145.947 |
| Net Profit/Loss - EUR | - | - | - | 21.559 | 20.554 | 21.576 | 34.813 | 11.603 | 34.765 | 145.692 |
| Employees | - | - | - | 3 | 5 | 3 | 4 | 4 | 4 | 3 |
Check the financial reports for the company - Bio Met Conf S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 351 | 59.129 | 43.701 | 122.566 | 164.812 |
| Current Assets | - | - | - | 22.386 | 48.488 | 63.420 | 19.053 | 48.211 | 234.183 | 72.957 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 757 | 23.217 | 45.830 | 16.064 | 23.576 | 218.419 | 47.235 |
| Cash | - | - | - | 21.629 | 25.271 | 17.590 | 2.989 | 24.635 | 5.655 | 15.671 |
| Shareholders Funds | - | - | - | 21.602 | 41.738 | 62.515 | 75.020 | 81.989 | 96.289 | 231.150 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 784 | 6.750 | 1.256 | 3.162 | 9.924 | 98.197 | -785 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 162.262 | 7.404 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2562 - 2562" | |||||||||
| CAEN Financial Year |
2562
|
|||||||||
Comments - Bio Met Conf S.r.l.